SYNJ2 and cancer: In addition, SYNJ2 was found related to the “DRUG METABOLISM CYTOCHROME P450” KEGG signaling pathway in several cancers (at least KICH, OV, and PCPG), indicating its druggable potential, which has also been demonstrated in BRCA before [14].